Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | CDK4 | P11802 | 2/20 | 0.30 |
| ▸ | CDK6 | Q00534 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19083199 | 0.82 | HRH3 (0.40) | — | |
| SCHEMBL16015435 | 0.82 | DPP7 (0.36) | EPHX2SLC6A4CDK4CDK6 | |
| SCHEMBL31491232 | 0.81 | — | — | |
| SCHEMBL22295955 | 0.77 | GAA (0.31) | EPHX2 | |
| SCHEMBL17743405 | 0.77 | — | — | |
| SCHEMBL9950713 | 0.77 | EPHX1 (0.40) | EPHX2SLC6A4 | |
| SCHEMBL4628123 | 0.75 | EPHX1 (0.43) | EPHX2 | |
| SCHEMBL7786057 | 0.75 | EPHX1 (0.43) | EPHX2 | |
| SCHEMBL1168484 | 0.75 | EPHX1 (0.43) | EPHX2 | |
| Hydrochloric Acid SCHEMBL18554671 | 0.74 | EPHX1 (0.42) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10562909-B2 | Fused quadracyclic compounds, compositions and uses thereof | Tabomedex Biosciences, LLC (US) | 2020-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10562909-B2 | Fused quadracyclic compounds, compositions and uses thereof | MKNK2, CYP2J2, PTGS2 | EPHX2 284/4885SLC6A4 4721/4885CDK4 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.